Differences in the regulation of microtubule stability by the pro-rich region variants of microtubule-associated protein 4  by Hasan, Mohammad Rubayet et al.
FEBS Letters 580 (2006) 3505–3510Diﬀerences in the regulation of microtubule stability by the
pro-rich region variants of microtubule-associated protein 4
Mohammad Rubayet Hasana, Mingyue Jina, Kazuyuki Matsushimab, Shigeaki Miyamotoa,
Susumu Kotanib, Hiroyuki Nakagawaa,c,*
a Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, Iizuka, Fukuoka 820-8502, Japan
b Department of Biological Sciences, Faculty of Science, Kanagawa University, Hiratsuka, Kanagawa 259-1293, Japan
c Division of Biology, Faculty of Science, Fukuoka University, Fukuoka, Fukuoka 814-0180, Japan
Received 27 March 2006; revised 2 May 2006; accepted 9 May 2006
Available online 15 May 2006
Edited by Michael R. BubbAbstract We have recently reported a neural variant of
microtubule-associated protein 4 with a short pro-rich region
(MAP4-SP). Here, we show that the neural MAP4 has reduced
microtubule-stabilizing activity, compared to the ubiquitous
MAP4 with a long pro-rich region (MAP4-LP), both in vitro
and in vivo. Fluorescence recovery after photobleaching analyses
revealed that the interaction of MAP4-SP with the microtubules
is very rapid, with a half-time of ﬂuorescence recovery of
7 ± 2.36 s, compared to 19.5 ± 3.03 s in case of MAP4-LP.
The dynamic interaction of MAP4-SP with microtubules in neu-
ral cells may contribute to the dynamic behaviors of extending
neurites.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Microtubule-associated protein 4 (MAP4) plays important
roles in the organization and dynamics of both interphase
and mitotic microtubules [1]. MAP4 proteins are composed
of an N-terminal projection domain and a C-terminal microtu-
bule-binding domain. The microtubule-binding domain of
MAP4 is highly conserved among the MAP4 proteins from
diﬀerent species and is partially homologous to the microtu-
bule-binding regions of brain MAPs, MAP2 and tau [2]. The
microtubule-binding domain of MAP4 is divided into three
sub-domains: (i) a region rich in proline and basic amino acid
residues (pro-rich region) that was suggested to promote the
nucleation of microtubule assembly; (ii) a region containing
3–5 imperfect repeats that was suggested to serve as an elonga-
tion-inducing factor for tubulin polymerization; and (iii) a
short hydrophobic C-terminal region [3,4]. The projectionAbbreviations: MAP, microtubule-associated protein; SP, short pro-
rich; LP, long pro-rich; FRAP, ﬂuorescence recovery after photoble-
aching; EGFP, enhanced green ﬂuorescent protein; EYFP, enhanced
yellow ﬂuorescent protein; RB, reassembly buﬀer; SDS–PAGE, sodi-
um dodecyl sulfate–polyacrylamide gel electrophoresis; ROI, region of
interest
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doi:10.1016/j.febslet.2006.05.028domain does not bind to the microtubules, but protrudes from
the microtubule wall as projections to suppress the microtu-
bule bundling and maintain spacing between microtubules [5].
Although the domain organizations of MAP4 proteins are
generally the same, several alternatively spliced variants of
MAP4 proteins have been reported. To date, four types of
MAP4 cDNAs were identiﬁed that diﬀer from each other in
the number or arrangement of the repeat sequences [6]. Recently,
we have identiﬁed a novel MAP4 isoform that lacks 72 consecu-
tive amino acid residues in the pro-rich region [7]. The expression
of the isoform is restricted to neural-ectoderm derived tissues
such as the brain and adrenal medulla. In vitro analyses, using
bacterially expressed truncated fragments, containing the micro-
tubule-binding domains of the isoform and the ubiquitous
MAP4 (termed ‘MAP4-LP’ for its long pro-rich region), revealed
only minor diﬀerence in their microtubule assembly promoting
activities. However, electron microscopy revealed that the
in vitro reconstituted microtubules induced by the MAP4-short
pro-rich (SP) fragment were single microtubules in contrast to
microtubule bundles induced by the MAP4-LP fragment [7]. In
this study, we demonstrate that the two proteins signiﬁcantly dif-
fer in their microtubule stabilizing functions both in vitro and
in vivo. In addition, the turnover of MAP4-SP on cytoplasmic
microtubules was more rapid than that of MAP4-LP. Taken to-
gether, our data suggest a speciﬁc role of MAP4-SP in the dy-
namic regulation of neural microtubules.2. Materials and methods
2.1. Materials
Taxol was kindly provided by N. Lomax (Division of Cancer Treat-
ment,NationalCancer Institute, Bethesda,MD,USA). Tubulinwas puri-
ﬁed from porcine brain as described previously [8,9]. The microtubule
binding domains of MAP4-LP and MAP4-SP were puriﬁed as described
earlier [7]. Construction of mammalian expression plasmids, pEGFP-C3-
MAP4-LP and pEGFP-C3-MAP4-SP, encoding full-length MAP4 pro-
teins as C-terminal fusions to enhanced green ﬂuorescent protein (EGFP),
are described elsewhere [10]. pEYFP-Tub, that encodes a fusion protein
consisting of enhanced yellow ﬂuorescent protein (EYFP) and human
a-tubulin was purchased from Clontech (CA, USA). Other reagents used
in the study were of reagent grade unless otherwise mentioned.2.2. In vitro microtubule stability assay
Tubulin (15 lM) was polymerized in 40 ll reaction mixtures in the
presence of MAP4 fragments (2 lM) (in triplicate) in reassembly buﬀer
(RB: 100 mM 2-morpholinoethanesulfonic acid, pH 6.8, 0.1 mM
ethylene glycol-bis(b-aminoethyl ether)-N,N,N 0,N 0-tetraacetic acid,blished by Elsevier B.V. All rights reserved.
Fig. 1. Stability of microtubules assembled in vitro in the presence of
MAP4-LP andMAP4-SP. (A) Schematic structures of the microtubule-
binding domains of MAP4-LP and MAP4-SP. The numbers in the
parentheses indicate the amino acid positions of the full-length MAP4-
LP. (B) Tubulin (15 lM) was mixed with the puriﬁed MAP4 fragments
(2 lM) and incubated at 37 C for microtubule assembly. After 30 min,
samples were either left untreated at the same temperature, or treated
with nocodazole to a ﬁnal concentration of 50 lg/ml, or diluted 10-times
by adding pre-warmed RB. All samples were incubated at 37 C for
further 10 min and centrifuged at 13000 rpm for 30 min. The resultant
supernatants andpelletswere analyzedbySDS–PAGE.Lanes 1, 3, 5, 7, 9
and11: tubulin + MAP4-LP; lanes 2, 4, 6, 8, 10 and12: tubulin + MAP4-
SP; lanes 1, 2, 7 and 8: control; lanes 3, 4, 9 and 10: nocodazole treatment;
lanes 5, 6, 11 and12: dilution.Lanes 11 and12 represent samples that had
10 times ﬁnal reaction volumes compared to other samples (see Section
2). Arrow: tubulin; open arrowhead: microtubule-binding domain of
MAP4-LP; closed arrowhead: microtubule-binding domain of MAP4-
SP. (C) Percent tubulin in the pellet fractions were calculated from the
data in A. Data were averaged from at least three independent
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incubation, one sample was left untreated to serve as control, in an an-
other sample, nocodazole was added to a ﬁnal concentration of 50 lg/
ml, and the third sample was diluted 10 times by adding pre-warmed
RB. All samples were incubated at 37 C for further 10 min and centri-
fuged at 16000 · g for 30 min. The pellets were resuspended in 40 ll
RB. Thus all supernatant and pellet fractions had a ﬁnal volume of
40 ll except that the supernatants of the dilution experiment remained
10 times diluted (400 ll). After the addition of an equal volume of so-
dium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
loading buﬀer, 15 ll from each sample was analyzed by electrophoresis
on a 10% SDS–polyacrylamide gel. For quantitative analysis, represen-
tative gels were prepared from three independent experiments. The
proportions of the amount of tubulin in the pellet and supernatant
fractions were determined by image analysis (ImageJ, NIH, USA). Be-
cause the supernatants of the dilution experiment remained 10 times
diluted, the staining intensity of tubulin bands from these samples were
multiplied by 10 to determine the relative proportions of tubulin in the
supernatant and pellet fractions.
2.3. Cell culture, transfection and live cell observation
Mouse neuroblastoma cell line, NG 108-15 cells and human hepa-
toma cell line, HepG2 cells were maintained in Dulbecco’s modiﬁed ea-
gle medium supplemented with 10% fetal calf serum and penicillin/
streptomycin at 37.5 C in 5% CO2. NG 108-15 cells were cultured
on coverslips coated with poly-L-lysine (0.01%) and laminine
(12.5 lg/ml), and HepG2 cells were cultured on collagen (0.1%)-coated
coverslips. Cells were transfected with 1 lg of diﬀerent constructs using
SuperFect transfection reagent (QIAGEN K.K., Tokyo, Japan)
according to the manufacturer’s instructions. Live cell observations
were made in a confocal laser-scanning microscope, Zeiss LSM510
(Carl Zeiss GmbH, Jena, Germany).
2.4. Nocodazole resistance assay in vivo
HepG2 cells expressing EYFP-tubulin, EGFP–MAP4-LP or EGFP–
MAP4-SP were treated with nocodazole (10 lg/ml). During the treat-
ment, ﬂuorescence images were collected every 5 min for a total of
90 min. All images were processed by ImageJ software. For quantita-
tive analyses, cells expressing EYFP-tubulin, EGFP–MAP4-LP or
EGFP–MAP4-SP were checked for remaining microtubules after
90 min of nocodazole treatment. The number of cells with remaining
microtubules was counted as a percentage of total cells, counted in
30 min. Data were analyzed from ﬁve independent experiments, and
at least 50 cells were counted per experiment, for each category.
2.5. Fluorescence recovery after photobleaching assay
HepG2 cells expressing EGFP–MAP4-LP or EGFP–MAP4-SP were
subjected to photobleaching using a Zeiss LSM 510 confocal micro-
scope. Areas of 20 lM2 were selected as region of interests (ROI)
and bleached with 2 iterations at 75% power. Post bleach images were
captured at every 2 s for a total of 120 s. Mean ﬂuorescence of each
ROI was corrected by background subtraction and the calculated frac-
tional ﬂuorescence recovery (%) was plotted against post bleach time.
Data were averaged from at least 10 experiments for each category.experiments. Error bars indicate S.D.s.3. Results
3.1. Stability of microtubules assembled in vitro in the presence
of MAP4-LP and MAP4-SP
Although MAP4-SP was shown to resemble many properties
with the MAP4-LP [7], the reduction of a signiﬁcant portion of
the microtubule-binding domain in MAP4-SP indicated the
possibility that these proteins might diﬀerentially regulate the
stability of microtubules in vitro. To investigate this possibility,
microtubule depolymerization was induced by the addition of
the anti-microtubule drug, nocodazole, in vitro. Puriﬁed frag-
ments of MAP4-LP and MAP4-SP, containing their microtu-
bule binding domains, were used for these analyses (Fig. 1A)
[7]. Although the diﬀerence in the amounts of assembled micro-tubules in control samples was very little (Fig. 1B, lanes 1 and 2),
MAP4-LP induced microtubules were more resistant to noco-
dazole than MAP4-SP induced microtubules (Fig. 1B, lanes 3
and 4). To further conﬁrm this result, microtubule disassembly
was also induced by dilution, and the remainingmicrotubules in
theMAP4-LP andMAP4-SP containing samples were collected
by centrifugation. To facilitate the comparison with the control
preparations (Fig. 1B, lanes 1 and 2), the microtubule pellets
(Fig. 1B, lanes 5 and 6) were resuspended in the same volume
of RB as it was used for the control pellets (see Section 2), while
the supernatant fractions (Fig. 1B, lanes 11 and 12) remained 10
times diluted. Consistent with the previous result, dilution
caused a profound reduction of microtubule quantity in the
MAP4-SP containing sample compared to that in the MAP4-
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tal tubulin amount of supernatant and pellet in the MAP4-LP
containing sample appeared to be diﬀerent from that of
MAP4-SP containing sample (Fig. 1B, lanes 5 + 11 and lanes
6 + 12), the total tubulin amounts are essentially the same if
the staining intensities of tubulin bands are normalized to com-
pensate for the diﬀerence in the reaction volumes of superna-
tants and pellets of this experiment. Quantitative analyses to
reveal the proportion of remaining microtubules after destabili-
zation indicated that MAP4-LP stabilized >85% and >65%
microtubules against disassembly induced by nocodazole and
dilution, respectively, while in case of MAP4-SP, the ﬁgures
were only 64% and 28%, respectively (Fig. 1C).
3.2. Cytoplasmic localization of MAP4-LP and MAP4-SP
With an aim to study the intracellular behavior of the neural
MAP4 as compared to the ubiquitous MAP4, the full-length
forms of these proteins were expressed as C-terminal fusions
to EGFP in mouse neuroblastoma cell line, NG 108-15 cells,
as well as in a non-neuronal cell line, HepG2 cells. Both pro-
teins had a typical ﬁlamentous distribution in the cytoplasm
of these cells (Fig. 2A–D). Treatment of the cells with the
microtubular inhibitor, nocodazole, disrupted their ﬁlamen-
tous distribution (Fig. 3A), indicating their localization with
the microtubules. The general organization of microtubules
was the same in the cells expressing MAP4-LP or MAP4-SP,
in either cell line. To investigate whether the MAP4-SP could
induce process formation in non-neuronal cells as it was re-
ported for the neural MAPs, MAP2 and tau [11,12], rat ﬁbro-
blastic cell line, 3Y1 cells were also transfected with the
EGFP–MAP4-SP construct. However, no process formation
was observed in MAP4-SP expressing cells and microtubule
organizations in these cells were similar to those expressing
MAP4-LP (data not shown), suggesting that, unlike MAP2Fig. 2. Microtubule organization in cells expressing MAP4-LP and
MAP4-SP. NG 108-15 cells (A, B) and HepG2 cells (C, D) were
transfected with EGFP–MAP4-LP construct (A, C) or EGFP–MAP4-
SP construct (B, D) as described in Section 2, and observed under a
confocal laser-scanning microscope, Zeiss LSM510 (Carl Zeiss
GmbH). Bars: 10 lm.and tau, MAP4-SP does not contribute much to the process
formation in non-neuronal cells, even though it is expressed
speciﬁcally in neural cells.3.3. Nocodazole resistance of microtubules in vivo
To investigate whether the MAP4 proteins diﬀer in their
ability to stabilize microtubules against disassembly by noco-
dazole in vivo, as it was observed in vitro, HepG2 cells were
expressed with EGFP–MAP4-LP and EGFP–MAP4-SP, and
were treated with nocodazole during live cell observations.
As a control, cells were expressed with YFP-tubulin to observe
the microtubule stability in normal cells. While microtubules
were completely depolymerized in control cells and MAP4-
SP expressing cells within 30 min of nocodazole treatment, a
signiﬁcant amount of microtubules remained in MAP4-LP
expressing cells even after 90 min (Fig. 3A). To conﬁrm this re-
sult, control and MAP4-expressing cells were counted after
treatment with nocodazole for 90 min, and scored for the num-
ber of cells with remaining microtubules. Microtubules were
remained in >80% cells expressing MAP4-LP as compared
with only about 17% and 5% of cells expressing MAP4-SP
and EYFP-tubulin, respectively (Fig. 3B). These data indicate
that MAP4-LP provides remarkable stability to microtubules
in vivo compared to MAP4-SP.3.4. Fluorescence redistribution rates of EGFP–MAP4-LP and
EGFP–MAP4-SP after photobleaching
Based on ﬂuorescence recovery after photobleaching
(FRAP) analysis, it was reported earlier that the microtubule
bound MAP4 continuously exchanges with the cytoplasmic
pool of MAP4 and the rate of this exchange varies from other
MAPs, as well as with the phases of cell growth [13]. To study
the dynamics of the binding of MAP4 isoforms, the cells
expressing EGFP–MAP4 proteins were used for FRAP analy-
sis. Since NG 108-15 cells move and change their shapes fre-
quently, aﬀecting the ﬂuorescence recovery measurement, we
used a more suitable cell line, HepG2 cells, for these analyses.
For precise analyses, clearly recognizable, single microtubules
on the nucleus were bleached. Data were rejected if there was
any variation in the microtubule network within the bleached
area. In all cases, the EGFP–MAP4 ﬂuorescence reappeared in
a ﬁlamentous pattern after photobleaching (Fig. 4A), indicat-
ing the dynamicity of the interaction of MAP4 proteins with
microtubules. In the bleached areas, the ﬂuorescence recovered
as a whole, and no polarity was observed as it was reported
earlier for MAP4 and MAP2 [13]. The total ﬂuorescence recov-
ery ranged from 80% to 90% for both proteins, but the ﬂuores-
cence recovery of EGFP–MAP4-SP was signiﬁcantly faster
than that of EGFP–MAP4-LP (Fig. 4B). As shown in Table
1, the T1/2 of ﬂuorescence recovery of MAP4-LP is >2-fold
higher than that of MAP4-SP, which is consistent with our
previous report on the binding aﬃnity of MAP4 proteins (Ta-
ble 1) [7]. MAP4-SP is thus proved to be more dynamic in its
interaction with microtubules both in vitro and in vivo.4. Discussion
Our study demonstrates that a recently reported neural var-
iant of MAP4, MAP4-SP, which lacks 72 consecutive amino
acid residues in the N-terminal portion of the pro-rich region,
Fig. 3. Nocodazole resistance of MAP4-LP and MAP4-SP decorated microtubules. (A) HepG2 cells were transfected with EGFP–MAP4-LP and
EGFP–MAP4-SP constructs as before, and nocodazole was added to a ﬁnal concentration of 10 lg/ml to the culture media during live cell
observations. Images were collected every 5 min for a total of 90 min. Control experiment was carried out in the same way except that the cells were
transfected with an YFP-tubulin construct to visualize microtubules. Bars: 10 lm. (B) Control and MAP4-expressing cells were treated with
nocodazole for 90 min, as before, and the percentage of cells with remaining microtubules was determined. Data were averaged from the results
obtained from ﬁve independent assays for each condition. At least 50 cells were counted in 30 min (90–120 min of nocodazole treatment) in each
assay. Error bars indicate S.D.s.
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ison with the ubiquitous MAP4 that contains the full-length
pro-rich region (MAP4-LP). While MAP4-LP provided great-er resistance to microtubules against disassembly, MAP4-SP
failed to provide any signiﬁcant stability to the microtubules
(Fig. 3). Since, MAP4 proteins are known to counteract micro-
Fig. 4. Fluorescence recovery of EGFP–MAP4-LP and EGFP–
MAP4-SP on microtubules after photobleaching. (A) HepG2 cells
were transfected with plasmids encoding EGFP–MAP4-LP and
EGFP–MAP4-SP. The marked regions were photobleached, and the
ﬂuorescence recoveries in the bleached region were imaged at 2 s
intervals for a total of 2 min. (B) Percent ﬂuorescence recovery was
calculated for each time point (see Section 2), and was plotted against
the post bleach time. The percent ﬂuorescence recovery at each time
point is an average of at least 10 independent measurements. Bars:
5 lm.
Table 1
Dynamics of MAP4-LP and MAP4-SP interaction with microtubules
Protein name T1/2 of ﬂuorescence
recovery (s)a
Dissociation constant
(lM) [7]
MAP4-LP 19.5 ± 3.03 0.14
MAP4-SP 7 ± 2.36 0.28
aPercent ﬂuorescence recovery as a function of time was ﬁtted with a
single exponential to obtain the T1/2 of ﬂuorescence recovery. Values
represent means ± S.D. n = > 10.
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reduction of this activity of the neural MAP4, while possessing
considerable assembly promoting activity [7], is unusual
among the MAP4 proteins. The inability of MAP4-SP to sta-
bilize microtubules in suﬃcient terms can be best explained by
the model proposed by Tokuraku et al. [3]. According to this
model, the pro-rich region of MAP4 facilitates the lateral asso-
ciation of protoﬁlaments by bridging the protoﬁlaments, and
thus favors microtubule growth over disassembly. The reduc-
tion of the length of the pro-rich region (30%) in MAP4-SP
could aﬀect its protoﬁlament-bridging activity and thereby
making the microtubules susceptible to disassembly. On the
other hand, the reduction of the length of the pro-rich region
may not be enough to aﬀect the assembly promoting activity
of MAP4-SP, signiﬁcantly.
Olmsted et al. [13] demonstrated that both MAP4 and
MAP2, on the microtubule surface, continuously exchanges
with their cytoplasmic pool like the tubulin molecules, and thatthe ﬂuorescence redistribution of these MAPs after photoble-
aching reﬂects the dynamicity of their interaction with micro-
tubules. By FRAP analysis, we found that the ﬂuorescence
from EGFP–MAP4-SP recovered much faster (>2 times) than
that of the EGFP–MAP4-LP. Because the ﬂuorescence recov-
ered on microtubules in a ﬁlamentous pattern, the diﬀerence in
the fractional ﬂuorescence recovery reﬂects a diﬀerence in the
dynamic behaviors of these proteins to interact with microtu-
bules in vivo. The faster recovery can be attributed to the re-
duced binding aﬃnity of MAP4-SP for microtubules
compared to that of MAP4-LP (Table 1) [7].
MAP4 proteins are considered to be the most abundant non-
tubulin components of microtubules in non-neuronal tissues. In
contrast, MAP4 is a minor component in neuronal tissues [14].
The low level expression of MAP4 may be important for these
cells, because MAP4 could suppress the remodeling of microtu-
bule cytoskeleton by its stabilizing eﬀect on microtubules dur-
ing neuronal diﬀerentiation. Numerous reports have shown
that the overexpression of MAP4 suppresses microtubule
dynamics and thus aﬀects the cell growth and division [14].
The neural cell speciﬁc expression of the MAP4-SP and its al-
tered regulatory roles may provide speciﬁc advantage to these
cells by providing more ﬂexibility to microtubules and thus
allowing rapid changes of microtubule-shapes, important for
neuronal remodeling and polarization [15]. Again, the rapid
interaction of MAP4-SP with microtubules could be advanta-
geous for organelle movement, or more speciﬁcally, for the
proper activity of the kinesin based axonal transport systems.
It was already shown that the overexpression of either full-
length MAP4 or its MTB domain directly inhibits the fre-
quency of microtubule based organelle movement [16]. Similar
results were also reported for the neuronal MAPs, MAP2 and
tau, which share similar microtubule-binding domains with
MAP4 [17–19]. Future studies aimed to determine the eﬀects
of MAP4-LP and MAP4-SP on the interactions of motor pro-
teins with microtubules, and investigations on their eﬀects on
organelle motility in vivo, might reveal the precise physiological
roles of the altered behaviors of the neural variant of MAP4.References
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